Michael Ulz
Stock Analyst at Morgan Stanley
(3.09)
# 2,696
Out of 4,556 analysts
561
Total ratings
44.4%
Success rate
2%
Average return
Main Sectors:
Stocks Rated by Michael Ulz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GUTS Fractyl Health | Maintained: Hold | $2 | $0.758 | +163.85% | 17 | Jul 15, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Hold | $370 → $400 | $266.99 | +49.82% | 46 | Jul 10, 2026 | |
| IONS Ionis Pharmaceuticals | Maintained: Buy | $130 → $110 | $54.01 | +103.67% | 37 | Jul 10, 2026 | |
| SRPT Sarepta Therapeutics | Maintained: Hold | $25 | $15.82 | +58.03% | 29 | Jun 30, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Buy | $100 | $88.70 | +12.74% | 25 | Jun 29, 2026 | |
| VKTX Viking Therapeutics | Maintained: Buy | $95 | $37.31 | +154.62% | 24 | Jun 24, 2026 | |
| BIOA BioAge Labs | Maintained: Hold | $23 | $21.94 | +4.83% | 14 | Jun 16, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $150 | $114.48 | +31.03% | 24 | Jun 15, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $136 | $103.97 | +30.81% | 20 | Jun 14, 2026 | |
| VIR Vir Biotechnology | Rated: Buy | $23 → $27 | $9.35 | +188.77% | 23 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $11.83 | +111.33% | 33 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $2.75 | +372.73% | 21 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $23.21 | +102.50% | 24 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.789 | +153.49% | 15 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $7.40 | +345.95% | 22 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $7 → $3 | $6.48 | -53.70% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $4.50 | -11.11% | 12 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $3.30 | +51.52% | 17 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.39 → $0.36 | $0.001 | +35,900.00% | 13 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $8.48 | n/a | 8 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $2.58 | n/a | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $5 | $12.00 | n/a | 2 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.5 | $4.07 | n/a | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.18 | n/a | 18 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.4405 | n/a | 3 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 | $28.78 | n/a | 12 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $60 → $23 | $5.17 | n/a | 2 | May 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $5.66 | n/a | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $3 | $31.59 | n/a | 2 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $58.40 | n/a | 15 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.43 | n/a | 12 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $27.65 | n/a | 13 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $36.11 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $35.00 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 | $851.72 | n/a | 6 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $69 → $60 | $5.93 | n/a | 2 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.60 | n/a | 3 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $22.05 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.6722 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $10.75 | n/a | 1 | Aug 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $8 | $0.0001 | n/a | 4 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $40 | $4.08 | n/a | 5 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $5.18 | n/a | 1 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $130.34 | n/a | 1 | May 18, 2010 |
Fractyl Health
Jul 15, 2026
Maintained: Hold
Price Target: $2
Current: $0.758
Upside: +163.85%
Alnylam Pharmaceuticals
Jul 10, 2026
Maintained: Hold
Price Target: $370 → $400
Current: $266.99
Upside: +49.82%
Ionis Pharmaceuticals
Jul 10, 2026
Maintained: Buy
Price Target: $130 → $110
Current: $54.01
Upside: +103.67%
Sarepta Therapeutics
Jun 30, 2026
Maintained: Hold
Price Target: $25
Current: $15.82
Upside: +58.03%
Arrowhead Pharmaceuticals
Jun 29, 2026
Maintained: Buy
Price Target: $100
Current: $88.70
Upside: +12.74%
Viking Therapeutics
Jun 24, 2026
Maintained: Buy
Price Target: $95
Current: $37.31
Upside: +154.62%
BioAge Labs
Jun 16, 2026
Maintained: Hold
Price Target: $23
Current: $21.94
Upside: +4.83%
Mirum Pharmaceuticals
Jun 15, 2026
Maintained: Buy
Price Target: $150
Current: $114.48
Upside: +31.03%
Rhythm Pharmaceuticals
Jun 14, 2026
Reiterated: Buy
Price Target: $136
Current: $103.97
Upside: +30.81%
Vir Biotechnology
Jun 11, 2026
Rated: Buy
Price Target: $23 → $27
Current: $9.35
Upside: +188.77%
Jun 11, 2026
Reiterated: Buy
Price Target: $25
Current: $11.83
Upside: +111.33%
Jun 3, 2026
Maintained: Buy
Price Target: $13
Current: $2.75
Upside: +372.73%
Jun 3, 2026
Reiterated: Buy
Price Target: $47
Current: $23.21
Upside: +102.50%
Jun 3, 2026
Reiterated: Buy
Price Target: $2
Current: $0.789
Upside: +153.49%
Jun 3, 2026
Maintained: Buy
Price Target: $33
Current: $7.40
Upside: +345.95%
May 15, 2026
Downgraded: Sell
Price Target: $7 → $3
Current: $6.48
Upside: -53.70%
May 13, 2026
Maintained: Hold
Price Target: $4
Current: $4.50
Upside: -11.11%
Mar 27, 2026
Maintained: Hold
Price Target: $5
Current: $3.30
Upside: +51.52%
Jan 8, 2026
Downgraded: Sell
Price Target: $0.39 → $0.36
Current: $0.001
Upside: +35,900.00%
Mar 11, 2025
Maintained: Buy
Price Target: $5
Current: $8.48
Upside: n/a
Mar 6, 2025
Maintained: Hold
Price Target: $5
Current: $2.58
Upside: n/a
Feb 11, 2025
Downgraded: Hold
Price Target: $20 → $5
Current: $12.00
Upside: n/a
Aug 13, 2024
Maintained: Sell
Price Target: $0.5
Current: $4.07
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $7.18
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $0.4405
Upside: n/a
Aug 22, 2023
Maintained: Hold
Price Target: $40
Current: $28.78
Upside: n/a
May 22, 2023
Rated: Buy
Price Target: $60 → $23
Current: $5.17
Upside: n/a
Jan 27, 2023
Downgraded: Hold
Price Target: $3
Current: $5.66
Upside: n/a
Jan 5, 2022
Maintained: Hold
Price Target: $7 → $3
Current: $31.59
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $58.40
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $1.43
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $27.65
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $36.11
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $35.00
Upside: n/a
Mar 4, 2021
Maintained: Buy
Price Target: $340
Current: $851.72
Upside: n/a
Mar 1, 2021
Maintained: Hold
Price Target: $69 → $60
Current: $5.93
Upside: n/a
Feb 16, 2021
Reiterated: Buy
Price Target: n/a
Current: $23.60
Upside: n/a
Jan 29, 2021
Maintained: Buy
Price Target: $37
Current: $22.05
Upside: n/a
Jan 29, 2021
Maintained: Buy
Price Target: $5
Current: $0.6722
Upside: n/a
Aug 12, 2020
Initiated Coverage: Buy
Price Target: $45
Current: $10.75
Upside: n/a
Jul 30, 2020
Maintained: Buy
Price Target: $15 → $8
Current: $0.0001
Upside: n/a
Mar 28, 2019
Maintained: Hold
Price Target: $3 → $40
Current: $4.08
Upside: n/a
Oct 3, 2017
Rated: Buy
Price Target: n/a
Current: $5.18
Upside: n/a
May 18, 2010
Maintained: Buy
Price Target: $28
Current: $130.34
Upside: n/a